Key Quantitative Figures - Standalone (Rs. in Lakhs)

Income Statement:

  • Revenue from operations: ₹5,916.66
  • Other income: ₹181.26
  • Total income: ₹6,097.92
  • Total expenses: ₹4,824.50
  • Profit before tax: ₹1,273.42
  • Tax expense: ₹327.83 (Current tax: ₹321.79, Deferred tax: ₹6.04)
  • Profit for the period: ₹945.59
  • Total comprehensive income for the period: ₹943.31

Earnings Per Share (Face value of ₹2 each):

  • Basic EPS: ₹2.29
  • Diluted EPS: ₹2.29

Capital Structure:

  • Paid-up equity share capital: ₹826.37 lakhs

Key Quantitative Figures - Consolidated (Rs. in Lakhs)

Income Statement:

  • Revenue from operations: ₹5,916.66
  • Other income: ₹181.26
  • Total income: ₹6,097.92
  • Total expenses: ₹4,824.50
  • Profit before tax: ₹1,273.42
  • Tax expense: ₹327.83
  • Profit for the period: ₹945.59
  • Share in profit of associate: ₹140.09
  • Total profit for the period: ₹1,085.68
  • Total comprehensive income for the period: ₹1,083.36

Earnings Per Share (Face value of ₹2 each):

  • Basic EPS: ₹2.63
  • Diluted EPS: ₹2.63

Capital Structure:

  • Paid-up equity share capital: ₹826.37 lakhs

Dates and Timeline

  • Board meeting date: August 13, 2026
  • Meeting duration: 3:00 PM to 3:40 PM
  • Quarter ended: June 30, 2026
  • Report date: August 13, 2026

Parties Involved

  • Statutory Auditors: A N S K & Associates (Firm Registration No. 026177N)
  • Associate Companies included in consolidation: Peptech Biosciences Limited and Titan Media Limited
  • Key signatories: Charanjit Singh (Company Secretary & Compliance Officer), Kapil Singal (Partner, A N S K & Associates), Naresh Kumar Singla (Managing Director)

Financial and Operational Impact

  • The results show significant year-over-year growth in both revenue and profitability
  • The consolidation includes results from two associate companies
  • Freight amount has been added in revenue from operations for sales calculation including GST, with corresponding addition in other expenses to neutralize the impact

Additional Information

  • The company has only one reportable business segment
  • Previous period figures have been regrouped/reclassified in line with the current period
  • The financial results are available on the BSE website (www.bseindia.com) and company website (www.titanbiotechltd.com)
  • The audit committee reviewed and the board of directors approved the results on August 13, 2026